Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00797849 · ClinicalTrials.gov registry record · NA
Controlled Study of Farabloc for Chronic Phantom Limb Pain Among Veteran Amputees
A NA study of Phantom Limb Pain, sponsored by Southern California Institute for Research and Education.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT00797849: Completed NA study of Phantom Limb Pain, sponsored by Southern California Institute for Research and Education.
NCT00797849 is a NA study of Phantom Limb Pain that has completed, run by Southern California Institute for Research and Education. The registered enrollment target is 57 participants, below the 118-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00797849, a NA study of Phantom Limb Pain, has completed, sponsored by Southern California Institute for Research and Education.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to determine if the group using Farabloc shows a greater reduction in pain levels than the group not using Farabloc at 6-week, 12-week and 1-month post treatment follow-ups.
Conditions Studied
Interventions
- DEVICE Farabloc Limb Cover
- DEVICE Sham Limb Cover
Study Locations (1)
California
- VA Long Beach Healthcare System - Long Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-11 |
| Phase | NA |
What the finished NCT00797849 record still lists
NCT00797849 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 118-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Phantom Limb Pain appearing as the primary indexed condition, and to 2 interventions - of which Farabloc Limb Cover is the first listed.
NCT00797849 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00797849 about?
NCT00797849 is a clinical study titled "Controlled Study of Farabloc for Chronic Phantom Limb Pain Among Veteran Amputees". The primary purpose of this study is to determine if the group using Farabloc shows a greater reduction in pain levels than the group not using Farabloc at 6-week, 12-week and 1-month post treatment follow-ups.
What is the current status of trial NCT00797849?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2008-11. Estimated completion is 2011-11.
What conditions does trial NCT00797849 study?
This clinical trial studies the following conditions: Phantom Limb Pain.
What interventions are being tested in trial NCT00797849?
The interventions under investigation include: Farabloc Limb Cover (DEVICE), Sham Limb Cover (DEVICE).
Who is sponsoring clinical trial NCT00797849?
This trial is sponsored by Southern California Institute for Research and Education, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00797849 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Phantom Limb Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00797849's enrollment target sits among peer trials
57 6th of 12 higher than 7 of 12 other Phantom Limb Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phantom Limb Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surgical Treatments for Postamputation Pain
RECRUITING · NA
-
Home-based Rehabilitation Intervention for Phantom Limb Pain in Veterans With Lower Limb Amputations
RECRUITING · NA
-
Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response
RECRUITING · NA
-
Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS)
ACTIVE NOT RECRUITING · NA
-
Closed-loop Deep Brain Stimulation to Treat Refractory Neuropathic Pain
ACTIVE NOT RECRUITING · NA
-
VR to Evaluate Phantom Limb Pain
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia